GLOPERBA Drug Patent Profile

✉ Email this page to a colleague

When do Gloperba patents expire, and what generic alternatives are available?

Gloperba is a drug marketed by Scilex Pharms and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.

This drug has three patent family members in two countries.

The generic ingredient in GLOPERBA is colchicine. There are sixteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the colchicine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Gloperba

A generic version of GLOPERBA was approved as colchicine by AMNEAL PHARMS on September 28^th, 2016.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for GLOPERBA?
What are the global sales for GLOPERBA?
What is Average Wholesale Price for GLOPERBA?

Summary for GLOPERBA

International Patents:	3
US Patents:	4
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	113
Clinical Trials:	1
Patent Applications:	4,088
Drug Prices:	Drug price information for GLOPERBA
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for GLOPERBA
What excipients (inactive ingredients) are in GLOPERBA?	GLOPERBA excipients list
DailyMed Link:	GLOPERBA at DailyMed

Drug patent expirations by year for GLOPERBA

Recent Clinical Trials for GLOPERBA

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Helwan University	Phase 3

See all GLOPERBA clinical trials

Pharmacology for GLOPERBA

Drug Class	Alkaloid

Paragraph IV (Patent) Challenges for GLOPERBA

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
GLOPERBA	Oral Solution	colchicine	0.6 mg/5 mL	210942	1	2020-04-02

US Patents and Regulatory Information for GLOPERBA

GLOPERBA is protected by four US patents.

Patents protecting GLOPERBA

Colchicine drug-to-drug interactions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Colchicine drug-to-drug interactions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD OF PROPHYLACTIC TREATMENT OF GOUT FLARES IN ADULTS COMPRISES ADMINISTERING TO A PATIENT A LIQUID COLCHICINE ORAL SOLUTION

Colchicine drug-to-drug interactions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Composition and method of use of colchicine oral liquid
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Scilex Pharms	GLOPERBA	colchicine	SOLUTION;ORAL	210942-001	Jan 30, 2019		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Scilex Pharms	GLOPERBA	colchicine	SOLUTION;ORAL	210942-001	Jan 30, 2019		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Scilex Pharms	GLOPERBA	colchicine	SOLUTION;ORAL	210942-001	Jan 30, 2019		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Scilex Pharms	GLOPERBA	colchicine	SOLUTION;ORAL	210942-001	Jan 30, 2019		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for GLOPERBA

See the table below for patents covering GLOPERBA around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
World Intellectual Property Organization (WIPO)	2019126579		⤷ Sign Up
European Patent Office	3426227	COMPOSITION ET MÉTHODE D'UTILISATION DE LIQUIDE ORAL DE COLCHICINE (COMPOSITION AND METHOD OF USE OF COLCHICINE ORAL LIQUID)	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2017156392		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration